Clinical significance of neutrophil CD177 mRNA expression in Ph‐negative chronic myeloproliferative disorders - Passamonti - 2004 - British Journal of Haematology - Wiley Online Library
Innovation in hematology. Perspectives: CML 2016 | Haematologica
PDF) High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study
DIPSS scores, pre-transplant therapy and chronic ... - Haematologica
Differences among young adults, adults and elderly chronic myeloid leukemia patients - Annals of Oncology
Chronic myeloid leukemia: room for improvement? | Haematologica
CML - Articoli - Storia delle nevicate a Pavia dal 1880 ad oggi - 4° parte
REFERENCE REFERENCES CYCLOPHOSPHAMIDE OR CHLORAMBUCIL THERAPY IS INDICATED IN IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH STRONG RISK
Innovation in hematology. Perspectives: CML 2016 | Haematologica
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis | Request PDF
Human herpes virus-6 seroprevalence and leukaemias: a case-control study
Ph-Positive CML in Blastic Phase with Monosomy 7 in a Down Syndrome Patient
Treatment of chronic myeloid leukemia in blast crisis | Haematologica
Incidence and outcomes of paediatric myelodysplastic syndrome in the United States - Xavier - 2018 - British Journal of Haematology - Wiley Online Library
World Mobile Token on Twitter: "@SundaeSwap @MinswapDEX @wingriderscom @MuesliSwapTeam @realmilkyswap @AstroSwapApp @occamDEX" / Twitter
Centro Meteorologico Lombardo
Interferon Alfa-2a as Compared with Conventional Chemotherapy for the Treatment of Chronic Myeloid Leukemia | NEJM
PDF) All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase
Ravendex on Twitter: "The best is yet to come" / Twitter
ABSTRACT BOOK - Haematologica
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study | Blood Cancer Journal
CML - Articoli - Storia delle nevicate a Pavia dal 1880 ad oggi - 2° parte